Latest Announcements

BSE & NSE corporate filings with AI summaries

BSEBoard MeetingFundraise11 Aug 2026

Natco Pharma Ltd

Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Further to our earlier intimation ....

Natco Pharma Ltd has informed BSE that the company's Board of Directors will meet on August 14, 2026 to consider raising funds through various methods, including public issue, preferential issue, rights issue, and private placement.

Read more →📎 1 attachment
BSECompany UpdateFundraise11 Aug 2026

Onix Solar Energy Ltd

Monitoring Agency Report

Onix Solar Energy Ltd has submitted its first Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI (ICDR) Regulations, 2018, stating that the proceeds from the preferential issue have been fully utilized by the Company for the purposes stated in the offer documents.

Read more →📎 1 attachment
BSEAGM/EGMFundraise11 Aug 2026

Kabra Extrusiontechnik Ltd

Notice of EGM

Kabra Extrusiontechnik Ltd has called an EGM to consider a preferential issue of up to 37.6 million equity shares to promoters and non-promoters at ₹375 per share, aggregating ₹141 crore.

Read more →📎 1 attachment
BSEBoard MeetingFundraise11 Aug 2026

Mangal Credit and Fincorp Ltd

Mangal Credit And Fincorp Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the proposal of fund ....

Mangal Credit and Fincorp Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 to consider and approve the proposal of fund raising by way of issuing Non-Convertible Debentures.

Read more →📎 1 attachment
BSEBoard MeetingFundraise11 Aug 2026

Viceroy Hotels Ltd

Viceroy Hotels Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Meeting of Rights Issue Committee ....

Viceroy Hotels Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve the terms and conditions of the Rights Issue, including the issue price, rights entitlement ratio, and record date.

Read more →📎 1 attachment
BSEBoard MeetingFundraise11 Aug 2026

HOMRE Ltd

HOMRE Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/08/2026 ,inter alia, to consider and approve for Implementation of ESOP and Preferential ....

HOMRE Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 19/08/2026 to consider and approve ESOP, preferential issue, and allotment of fully convertible warrants, and to approve the notice of Annual General Meeting.

Read more →📎 1 attachment
BSECompany UpdateFundraise11 Aug 2026

Ambassador Intra Holdings Ltd

Outcome of Board Meeting held on 11th August, 2026 for Issue of warrants on Preferential basis

Ambassador Intra Holdings Ltd has announced the outcome of its Board Meeting held on 11th August, 2026, where it approved the issue of up to 18,00,000 warrants convertible into equity shares on a preferential basis. The warrants will be issued to public category investors at an issue price determined by the Board. The company also approved the Notice convening the 44th Annual General Meeting, the related explanatory statements, and other documents to be circulated to members.

Read more →📎 1 attachment
BSECompany UpdateFundraise11 Aug 2026

Ceinsys Tech Ltd

Disclosure under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015 - Statement of Deviation or Variation of funds raised through Preferential Allotment ....

Ceinsys Tech Ltd has made a disclosure under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding a deviation in the utilization of funds raised through a preferential allotment of equity shares and convertible share warrants. The company has received 100% consideration in cash for the total amount of Rs. 6169 Cr against 11,01,749 equity shares and Rs. 17337 Cr against 30,96,515 share warrants. The deviation is due to a revision in the subscribed amount and the estimated amount to be utilized for each of the objects.

Read more →📎 1 attachment
BSECompany UpdateFundraise11 Aug 2026

Continental Chemicals Ltd

AS PER THE DOCUMENT ATTACHED

Continental Chemicals Ltd has submitted a statement of deviation and variation in the utilization of funds raised through a preferential issue for the quarter ended June 2026, as per Regulation 32 of SEBI (LODR) Regulations, 2015.

Read more →📎 1 attachment